full2010.pdf - page 568

530
O63
Ÿ¨…°Š„µ¦Á¦·
¤Ãž¦˜¸
œ„´
—‹µ„™´É
ªÁ®¨º
°Š˜n
°¦³—´
œÊÎ
µ˜µ¨ ¦¼
žÂ¦³—´
Å…¤´
œÂ¨³ C-reactive
protein ĜÁ¨º
°—®¨´
Š°—°µ®µ¦ ĜŸ¼o
ži
ª¥Ã¦‡Áµ®ªµœœ·
—š¸É
2
Effects of Soy Protein Isolate Supplementation on Fasting Blood Glucose Lipid Profile and
C-Reactive Protein in Type 2 Diabetic Patients
Á°¤°¦ ´
¥ž¦³š¸
ž
1*
¨³°¦°œŠ‡r
„´
Š—µ¨°Î
揭
2
Em-on Chaiprateep
1*
and Oranong Kangsadalampai
2
š‡´
—¥n
°
„µ¦«¹
„¬µœ¸Ê
¤¸
ª´
˜™»
ž¦³Š‡r
Á¡ºÉ
°«¹
„¬µŸ¨„µ¦Á¦·
¤Ãž¦˜¸
œ„´
—‹µ„™´É
ªÁ®¨º
°Š˜n
°¦³—´
œÊÎ
µ˜µ¨ ¦¼
žÂ¦³—´

Ņ¤´
œ ¨³ high sensitivity C-reactive protein (hs-CRP) ĜŸ¼o
ži
ª¥Áµ®ªµœœ·
—š¸É
2 ž¦³„°—o
ª¥Ÿ¼o
ži
ª¥Áµ®ªµœ
œ·
—š¸É
2 š¸É
¤´
‡¦Á…o
µ¦n
ª¤„µ¦ª·
‹´
¥ ‹Î
µœªœ 36 ‡œ ŗo
¦´
‡Î
µÂœ³œÎ
µ—o
µœÃ£œÎ
µ´
—Î
µ®¦´
Ÿ¼o
ži
ª¥Áµ®ªµœ ¨³™¼
„n
Š
»n
¤°°„Áž}
œ 2 „¨»n
¤ ‡º
° „¨»n
¤š—¨°Š (ŗo
¦´
Ãž¦˜¸
œ„´
—‹µ„™´É
ªÁ®¨º
°Šª´
œ¨³ 30 „¦´
¤ Ž¹É
Š¤¸
ž¦·
¤µ–Å°ÃŽ¢¨µ
êœr
32 ¤·
¨¨·
„¦´
¤ Áž}
œÁª¨µ 6 ´
ž—µ®r
) ¨³„¨»n
¤‡ª‡»
¤ (Ťn
ŗo
¦´
Ãž¦˜¸
œ„´
—‹µ„™´É
ªÁ®¨º
°Š) šÎ
µ„µ¦ª´
—´
—n
ªœ
…°Š¦n
µŠ„µ¥ ¦³—´
œÊÎ
µ˜µ¨ Ņ¤´
œ ¨³ hs-CRP Ž¹É
ŠÁž}
œ˜´
ªn
Š¸Ê
šµŠ¸
ª£µ¡…°Š„µ¦Á„·
Ѿਫ
ªÄ‹Â¨³®¨°—Á¨º
°— Á¤ºÉ
°
Á¦·É
¤˜o
œÂ¨³´
ž—µ®r
š¸É
6 …°Š„µ¦ª·
‹´
¥ ¡ªn
µ´
—n
ªœ…°Š¦n
µŠ„µ¥ ¦³—´
œÊÎ
µ˜µ¨ Ņ¤´
œ ¨³ hs-CRP ¦³®ªn
µŠ„¨»n
¤
š—¨°ŠÂ¨³„¨»n
¤‡ª‡»
¤Å¤n
¤¸
‡ªµ¤Â˜„˜n
µŠ„´
œ°¥n
µŠ¤¸
ϫ
¥Î
µ‡´
 ˜n
°¥n
µŠÅ¦„È
˜µ¤Äœ„¨»n
¤š—¨°Š¤¸
¦³—´
 HbA1c ¨—¨Š
Á¤ºÉ
°Áž¦¸
¥Áš¸
¥„´
‡n
µÁ¦·É
¤˜o
œ°¥n
µŠ¤¸
ϫ
¥Î
µ‡´
šµŠ™·
˜·
(
p
=0.003)
Î
µ®¦´
¦³—´
Å…¤´
œÄœÁ¨º
°—¡ªn
µ¦³—´

‡°Á¨Á˜°¦°¨¦ª¤ °¨—¸
°¨-‡°Á¨Á˜°¦°¨ ¨³Å˜¦„¨¸
ÁŽ°Å¦—r
¨—¨ŠÄœ„¨»n
¤š—¨°Š¤µ„„ªn
µ„¨»n
¤‡ª‡»
¤ ¨³
¡ªn
µ¦³—´
‡°Á¨Á˜°¦°¨¦ª¤¨—¨Š‹µ„‡n
µÁ¦·É
¤˜o
œ°¥n
µŠ¤¸
ϫ
¥Î
µ‡´
ÄœŸ¼o
ži
ª¥Äœ„¨»n
¤š—¨°Šš¸É
¤¸
¦³—´
‡°Á¨Á˜°¦°¨
Á¤ºÉ
°Á¦·É
¤˜o
œ„µ¦š—¨°Š¤µ„„ªn
µ 5.18 ¤·
¨¨·
䨘n
°¨·
˜¦ (200 ¤·
¨¨·
„¦´
¤˜n
°Á—Ž·
¨·
˜¦) (
p
=0.04) œ°„‹µ„œ¸Ê
¥´
Š¡ªn
µ hs-
CRP ¤¸
‡ªµ¤´
¤¡´
œ›r
ĜšµŠª„„´
 HbA1c (
r
= 0.33) °¥n
µŠ¤¸
ϫ
¥Î
µ‡´
šµŠ™·
˜·
—´
Šœ´Ê
œ „µ¦Á¦·
¤Ãž¦˜¸
œ„´
—‹µ„™´É
ª
Á®¨º
°ŠÄœŸ¼o
ži
ª¥Ã¦‡Áµ®ªµœœ·
—š¸É
2 šÎ
µÄ®o
µ¤µ¦™‡ª‡»
¤˜´
ªn
Š¸Ê
šµŠ¸
ª£µ¡µŠ˜´
ªÅ—o
Ž¹É
Š°µ‹Áž}
œž¦³Ã¥œr
Ĝ
„µ¦¨—‡ªµ¤Á¸É
¥Š˜n
°„µ¦Á„·
Ѿਫ
ªÄ‹Â¨³®¨°—Á¨º
°—ÄœŸ¼o
ži
ª¥Ã¦‡Áµ®ªµœœ·
—š¸É
2
‡Î
µÎ
µ‡´
:
Þ¦˜¸
œ„´
—‹µ„™´É
ªÁ®¨º
°Š ˜´
ªn
Š¸Ê
šµŠ¸
ª£µ¡…°Š„µ¦Á„·
Ѿਫ
ªÄ‹Â¨³®¨°—Á¨º
°— æ‡Áµ®ªµœœ·
—š¸É
2
1
œ·
·
˜ž¦·
µÃš £µ‡ª·
µ°µ®µ¦Â¨³Á£´
Á‡¤¸
‡–³Á£´
«µ˜¦r
‹»
¯µ¨Š„¦–r
¤®µª·
š¥µ¨´
¥
Master’s Degree Student, Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical,
Chulalongkorn University
* Corresponding author: Ú¦«´
¡šr
0 8006 6091 E-mail:
,
2
°µ‹µ¦¥r
—¦. £µ‡ª·
µ°µ®µ¦Â¨³Á£´
Á‡¤¸
‡–³Á£´
«µ˜¦r
‹»
¯µ¨Š„¦–r
¤®µª·
š¥µ¨´
¥
Dr., Department Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical, Chulalongkorn University
1...,558,559,560,561,562,563,564,565,566,567 569,570,571,572,573,574,575,576,577,578,...2023
Powered by FlippingBook